SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $44 | -99.9% | 14 | 0.0% | 0.00% | – |
| Q3 2022 | $69,000 | +19.0% | 14 | 0.0% | 0.00% | – |
| Q2 2022 | $58,000 | -28.4% | 14 | 0.0% | 0.00% | – |
| Q1 2022 | $81,000 | -22.9% | 14 | 0.0% | 0.00% | – |
| Q4 2021 | $105,000 | -16.7% | 14 | 0.0% | 0.00% | – |
| Q3 2021 | $126,000 | -25.0% | 14 | 0.0% | 0.00% | – |
| Q2 2021 | $168,000 | -4.0% | 14 | 0.0% | 0.00% | – |
| Q1 2021 | $175,000 | -19.7% | 14 | 0.0% | 0.00% | – |
| Q4 2020 | $218,000 | +65.2% | 14 | 0.0% | 0.00% | – |
| Q3 2020 | $132,000 | +5.6% | 14 | 0.0% | 0.00% | – |
| Q2 2020 | $125,000 | +40.4% | 14 | 0.0% | 0.00% | – |
| Q1 2020 | $89,000 | -23.9% | 14 | 0.0% | 0.00% | – |
| Q4 2019 | $117,000 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |